| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
EcstasyImmunosuppressive agentsImmune deviation| 1 | 2003 | The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). | 
| + | - | nl | Pharmacol Rev 55(3):463-508 (2003) |
| 2 | 2009 | The harmful health effects of recreational ecstasy: a systematic review of observational evidence. |
| + | - | nl | Health Technol Assess 13(6):iii-iv, ix-xii, 1-315 (2009) |
| 3 | 2004 | Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): a stressor on the immune system. |
| + | - | nl | Immunology 111(4):357-67 (2004) |
| 4 | 2001 | The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs. |
| + | - | nl | CMAJ 165(7):917-28 (2001) |
| 5 | 2010 | Methylenedioxymethamphetamine ('Ecstasy')-induced immunosuppression: a cause for concern? | 
| + | - | nl | Br J Pharmacol 161(1):17-32 (2010) |
| 6 | 2006 | Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management. |
| + | - | nl | Br J Anaesth 96(6):678-85 (2006) |
| 7 | 2008 | The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the kidney. |
| + | - | nl | Clin J Am Soc Nephrol 3(6):1852-60 (2008) |
